Table 1.
Age, start times, end times and duration of the sedation effect in children undergoing procedural sedation by intranasal Midazolam and Ketamine and MOPS achieved in both the sedation and placebo groups
| Parameter | Mean | IC 95% | Median | IC 95% | Standard deviation | Min | Max |
|---|---|---|---|---|---|---|---|
|
Age (mths) sedation |
41.5 |
24.2 to 58.9 |
31.0 |
18.8 to 49.3 |
36.0 |
13 |
168 |
|
Age (mnths) placebo |
40.6 |
21.3 to 59.9 |
33.0 |
19.2 to 48.7 |
34.8 |
14 |
152 |
|
Start time sedation |
22.9 |
19.2 to 26.6 |
24 |
15.4 to 26.6 |
13.7 |
6 |
60 |
|
Effect (min) sedation | |||||||
|
Start time sedation |
Na# |
na |
na |
na |
na |
na |
|
|
Effect (min) placebo | |||||||
|
End time sedation effect (min) sedation |
77.9 |
70.1 to 85.7 |
80 |
75.0 to 84.0 |
29.2 |
30 |
180 |
|
End time sedation effect (min) placebo |
Na |
na |
na |
na |
na |
na |
Na |
|
Duration of sedation effect (min) sedation |
71.5 |
63.8 to 79.3 |
72.0 |
65.6 to 76.6 |
28.9 |
25 |
176 |
|
Duration of sedation effect (min) placebo |
Na |
na |
na |
na |
na |
na |
Na |
|
MOPS sedation* (IQR) |
3.5 |
3.1 to 3.9 |
4.0 |
3.0 to 4.0 |
1.6 |
1 |
8 |
|
(2.5-4) | |||||||
| MOPS placebo* (IQR) | 7.2 | 6.9 to 7.6 | 7 | 7.0 to 8.0 | 1.4 | 4 | 9 |
| (6-8) |
*p <0.0001.
#na: not applicable due to no effects of placebo.